The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
BlackRock Health Sciences Opps K SHSKX
- NAV / 1-Day Return 77.02 / −0.76 %
- Total Assets 8.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.750%
- Distribution Fee Level Low
- Share Class Type Retirement, Large
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 5.0 Mil
- Status Open
- TTM Yield 0.49%
- Turnover 27%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 12:33 AM GMT+0
Morningstar’s Analysis SHSKX
Will SHSKX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
UnitedHealth Group Inc | 9.31 | 787.1 Mil | Healthcare |
Eli Lilly and Co | 8.48 | 716.8 Mil | Healthcare |
Boston Scientific Corp | 5.35 | 452.2 Mil | Healthcare |
Amgen Inc | 4.06 | 342.8 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.75 | 317.3 Mil | Healthcare |
Danaher Corp | 3.56 | 301.1 Mil | Healthcare |
AbbVie Inc | 3.27 | 276.4 Mil | Healthcare |
BlackRock Liquidity T-Fund Instl | 3.26 | 275.2 Mil | Cash and Equivalents |
Intuitive Surgical Inc | 3.19 | 270.0 Mil | Healthcare |
Elevance Health Inc | 2.95 | 249.6 Mil | Healthcare |